---
title: "Pharming Group (PHAR) Gets a Buy from Canaccord Genuity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285756521.md"
description: "Canaccord Genuity analyst Whitney Ijem has maintained a Buy rating on Pharming Group (PHAR) with a price target of $37.00. Ijem, a 5-star analyst, has an average return of 24.8% and a 50.70% success rate. Additionally, Oppenheimer also issued a Buy rating for the stock, setting a price target of $40.00."
datetime: "2026-05-08T16:59:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285756521.md)
  - [en](https://longbridge.com/en/news/285756521.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285756521.md)
---

# Pharming Group (PHAR) Gets a Buy from Canaccord Genuity

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Pharming Group today and set a price target of $37.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Ijem is a 5-star analyst with an average return of 24.8% and a 50.70% success rate. Ijem covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Alnylam Pharma, and Arcturus Therapeutics.

In a report released today, Oppenheimer also maintained a Buy rating on the stock with a $40.00 price target.

### Related Stocks

- [PHAR.US](https://longbridge.com/en/quote/PHAR.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)

## Related News & Research

- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [AstraZeneca's blood pressure drug wins U.S. approval](https://longbridge.com/en/news/286720674.md)
- [This Analyst Just Sent Mobileye Stock Down. Here's Why.](https://longbridge.com/en/news/286817003.md)
- [Core Scientific Is Firing on All Cylinders as Analysts Approve Its Expansion Plans](https://longbridge.com/en/news/286808678.md)
- [Do Wall Street Analysts Like Equity Residential Stock?](https://longbridge.com/en/news/286806057.md)